VECTURA
DEAD

Serial Number

97794244

Owner

Vectura Fertin Pharma, Inc.

Attorney

Tamar Niv Bessinger

Filing Date

Feb 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VECTURA Trademark

Serial Number: 97794244

VECTURA is a trademark filed by Vectura Fertin Pharma, Inc. on February 14, 2023. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

Vectura Fertin Pharma, Inc. (4 trademarks)

677 Washington Blvd
Stamford, CT 06901

Entity Type: 03

Trademark Details

Filing Date

February 14, 2023

Registration Date

Not Registered

Published for Opposition

July 30, 2024

Goods & Services

Coffee, tea, cocoa, sugar, rice, tapioca, sago, coffee substitutes and flour; food preparations of cereals being namely, cereal bars, cereal-based snack food and high protein cereal bars; bread, pastry and confectionery made of sugar; non-medicated chewing gum; ice cream; honey; yeast; baking powder; salt; mustard; vinegar, including wine vinegar, sauces, spices, raw ice being ice

Education, namely, providing of training in relation to pharmaceuticals, drug delivery devices, healthcare and wellbeing

Scientific, research, navigation, surveying, photographic, cinematographic, audiovisual, optical, weighing, measuring, signaling, detecting, testing, inspecting, life-saving and teaching apparatus and instruments, namely cameras and weighing scales; smartwatches; wearable activity trackers; wearable computers in the nature of smart-glasses used to monitor sleep, energy and stress; downloadable electronic books and magazines in the field of health, wellness, sleep, energy and stress; air analysis apparatus; recorded and downloadable media, namely podcasts and sound recordings featuring content concerning health, wellness, sleep, energy and stress; downloadable and recorded computer software platforms for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; downloadable computer software applications for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress; downloadable computer programs for wireless data communication for receiving, processing, transmitting and displaying information featuring content concerning health, wellness, sleep, energy and stress

Pharmaceutical products, namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders pharmaceutical preparations for inhalation for treatment of a wide variety of diseases and conditions, namely smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; pharmaceutical preparations for treatment of a wide variety of diseases and conditions, namely smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders in chewable form, in gum form, in lozenge form, and in pouch powder form; vitamins and dietary supplements; dietetic foods adapted for medical purposes; nicotine chewing gum for use as an aid to stop smoking; medicated chewing gum; dietetic preparations for medical use; herbal extracts for medical purposes; herbal teas for medicinal purposes; air purifying preparations; aerosolized or inhaled therapeutics and pharmaceuticals namely, smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders

Bleaching preparations and other substances being laundry detergent for laundry use; cleaning, polishing, scouring and abrasive cleaning preparations, nonmedicated cosmetic soap, perfumery, essential oils, cosmetics, hair lotions, dentifrices, nonmedical oral hygiene preparations, namely mouthwashes, not for medical purposes; toothpaste; bath preparations, not for medical purposes

Medical services; medical services in the area of inhaled therapeutics and medical and pharmaceutical consultation in the field of pharmaceuticals and in the area of oral administration of pharmaceuticals; dietary and nutritional advice; health care services.

Medical devices, namely inhalers for medical purposes, sold empty; medical devices for use for inhalation being inhalers sold empty; aerosol dispensers for medical purposes being inhalers for medical purposes, sold empty; dry powder inhalers (DPI) sold empty for medical purposes; nebulizers for medical purposes; pressurized metered-dose inhalers (pMDI) for medical purposes, sold empty; pulmonary drug delivery devices being delivery catheters, implantable drug delivery pumps, drug delivery patches sold without medication

Scientific and technological services namely research and design in the field of smoking cessation preparations, analgesic preparations, sleep aid-preparations, anti-pyretic and anti-inflammatory preparations, preparations for the treatment of arthritis, preparations having psychotherapeutic properties, preparations for treatment of cold, flu, cough, sinus, allergy, cardiovascular emergencies, neurological conditions, chronic pain management, and gastro-intestinal disorders; medical research services; scientific research services; pharmaceutical development services; formulation being research, and development of inhaled therapeutics; formulation being research, and development of pharmaceutical and well-being products for oral and intra-oral delivery systems

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 28, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 28, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 20, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 20, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 20, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 20, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 27, 2024 GNFN
FINAL REFUSAL E-MAILED
May 27, 2024 GNFR
FINAL REFUSAL WRITTEN
May 27, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 14, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 14, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 13, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jun 22, 2023 AMPX
ASSIGNED TO LIE
Jun 22, 2023 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2023 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 23, 2023 PARI
NEW APPLICATION ENTERED
Feb 17, 2023 NWAP